Dataset from An Open-label, Multicenter, Phase 2 Study of Oral IXAZOMIB (MLN9708) in Adult Patients With Relapsed and/or Refractory Follicular Lymphoma
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00007114
下载链接
链接失效反馈官方服务：
资源简介：
The primary purpose of this study is to evaluate the anti-tumor activity of oral Ixazomib as
measured by overall response rate (ORR) in adult participants with relapsed and/or refractory
follicular lymphoma (FL).
创建时间：
2025-10-01
